Literature DB >> 6987173

Rate of clearance of virulent Treponema pallidum (Nichols) from the blood stream of normal, Mycobacterium bovis BCG-treated, and immune syphilitic rabbits.

S Graves.   

Abstract

The rate of clearance of virulent Treponema pallidum (Nichols) from the blood stream of normal rabbits and rabbits previously treated with Mycobacterium bovis BCG was similar, there being treponemes still circulating 8 h after intravenous inoculation. In contrast, immune syphilitic rabbits cleared the virulent treponemes within 1 to 2 hours. Rabbits with passive humoral immunity to T. pallidum (after the transfer of 70 ml of immune serum) showed a similar clearance rate to that of the immune rabbits. Rabbits previously treated with BCG and with passive humoral immunity did not show a synergistic enhanced clearance rate, it being similar to that of immune rabbits.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6987173      PMCID: PMC550754          DOI: 10.1128/iai.27.1.264-267.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  18 in total

1.  Demonstration of particulate adhesion of the Rieckenberg type with the spirochete of syphilis.

Authors:  C LAMANNA; D H HOLLANDER
Journal:  Science       Date:  1956-06-01       Impact factor: 47.728

2.  The immune-adherence phenomenon; an immunologically specific reaction between microorganisms and erythrocytes leading to enhanced phagocytosis.

Authors:  R A NELSON
Journal:  Science       Date:  1953-12-18       Impact factor: 47.728

3.  Treponema pallidum opsonophagocytic test.

Authors:  M Metzger; E Michalska
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  1974       Impact factor: 4.291

4.  The immunology of syphilis.

Authors:  D M Musher; R F Schell; J M Knox
Journal:  Int J Dermatol       Date:  1976-10       Impact factor: 2.736

5.  Effect of pretreatment with Mycobacterium bovis (strain BCG) and immune syphilitic serum on rabbit resistance to Treponema pallidum.

Authors:  S R Graves; R C Johnson
Journal:  Infect Immun       Date:  1975-11       Impact factor: 3.441

6.  Humoral immunity in experimental syphilis. II. The relationship of neutralizing factors in immune serum to acquired resistance.

Authors:  N H Bishop; J N Miller
Journal:  J Immunol       Date:  1976-07       Impact factor: 5.422

7.  Effect macrophage activation on infection with Treponema pallidum.

Authors:  R Schell; D Musher; K Jacobson; P Schwethelm; C Simmons
Journal:  Infect Immun       Date:  1975-09       Impact factor: 3.441

8.  Attachment of virulent Treponema pallidum to human mononuclear phagocytes.

Authors:  B D Brause; R B Roberts
Journal:  Br J Vener Dis       Date:  1978-08

9.  Effect of sensitization with Propionibacterium acnes on the growth of Listeria monocytogenes and Treponema pallidum in rabbits.

Authors:  R E Baughn; D M Musher; J M Knox
Journal:  J Immunol       Date:  1977-01       Impact factor: 5.422

10.  Characterization of the attachment of Treponema pallidum (Nichols strain) to cultured mammalian cells and the potential relationship of attachment to pathogenicity.

Authors:  T J Fitzgerald; R C Johnson; J N Miller; J A Sykes
Journal:  Infect Immun       Date:  1977-11       Impact factor: 3.441

View more
  3 in total

1.  Treponemal infection specifically enhances node T-cell regulation of macrophage activity.

Authors:  D R Tabor; O Bagasra; R F Jacobs
Journal:  Infect Immun       Date:  1986-10       Impact factor: 3.441

2.  Immunization of guinea pigs with recombinant TmpB antigen induces protection against challenge infection with Treponema pallidum Nichols.

Authors:  K Wicher; L M Schouls; V Wicher; J D Van Embden; S S Nakeeb
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

3.  Effect of syphilitic rabbit sera taken at different periods after infection on treponemal motility, treponemal attachment to mammalian cells in vitro, and treponemal infection in rabbits.

Authors:  G H Wong; B Steiner; S Graves
Journal:  Br J Vener Dis       Date:  1983-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.